Integer (NYSE:ITGR) Updates FY 2025 Earnings Guidance

Integer (NYSE:ITGR - Get Free Report) issued an update on its FY 2025 earnings guidance on Thursday morning. The company provided earnings per share guidance of 6.250-6.510 for the period, compared to the consensus earnings per share estimate of 6.314. The company issued revenue guidance of $1.9 billion-$1.9 billion, compared to the consensus revenue estimate of $1.9 billion.

Integer Trading Up 1.0%

ITGR traded up $1.07 on Friday, reaching $108.17. 614,623 shares of the company's stock were exchanged, compared to its average volume of 474,587. The company's 50 day moving average is $118.78 and its 200-day moving average is $123.71. The company has a market cap of $3.77 billion, a price-to-earnings ratio of 47.65, a PEG ratio of 0.92 and a beta of 0.98. Integer has a twelve month low of $104.93 and a twelve month high of $146.36. The company has a debt-to-equity ratio of 0.72, a quick ratio of 2.14 and a current ratio of 3.41.

Integer (NYSE:ITGR - Get Free Report) last issued its quarterly earnings data on Thursday, July 24th. The medical equipment provider reported $1.55 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.57 by ($0.02). Integer had a net margin of 4.61% and a return on equity of 12.27%. The firm had revenue of $476.00 million during the quarter, compared to analyst estimates of $464.37 million. During the same period last year, the business earned $1.30 EPS. The firm's revenue was up 11.4% compared to the same quarter last year. Equities analysts predict that Integer will post 6.01 earnings per share for the current year.

Analysts Set New Price Targets

A number of analysts have recently weighed in on the stock. Wells Fargo & Company decreased their price target on shares of Integer from $152.00 to $132.00 and set an "overweight" rating for the company in a research report on Friday. Benchmark lowered their price target on Integer from $150.00 to $140.00 and set a "buy" rating on the stock in a report on Friday, April 25th. Citigroup raised shares of Integer from a "hold" rating to a "strong-buy" rating and upped their price objective for the company from $133.00 to $140.00 in a research note on Thursday, May 22nd. Truist Financial lowered their target price on Integer from $145.00 to $137.00 and set a "buy" rating on the stock in a research note on Friday. Finally, Raymond James Financial reduced their price target on Integer from $150.00 to $143.00 and set an "outperform" rating for the company in a report on Friday. Two investment analysts have rated the stock with a hold rating, seven have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average price target of $140.25.

Insider Buying and Selling at Integer

In other news, Director Martin C. Maxwell sold 8,720 shares of the company's stock in a transaction on Thursday, June 5th. The stock was sold at an average price of $120.56, for a total transaction of $1,051,283.20. Following the transaction, the director owned 22,170 shares of the company's stock, valued at $2,672,815.20. This represents a 28.23% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Joseph W. Dziedzic sold 338,975 shares of the stock in a transaction dated Thursday, May 1st. The shares were sold at an average price of $123.17, for a total value of $41,751,550.75. Following the completion of the transaction, the chief executive officer directly owned 47,000 shares in the company, valued at $5,788,990. The trade was a 87.82% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 362,434 shares of company stock worth $44,577,115 over the last three months. Company insiders own 2.16% of the company's stock.

Hedge Funds Weigh In On Integer

Several hedge funds have recently added to or reduced their stakes in ITGR. United Services Automobile Association bought a new stake in shares of Integer in the first quarter worth about $258,000. Jones Financial Companies Lllp grew its holdings in shares of Integer by 79,888.9% during the first quarter. Jones Financial Companies Lllp now owns 7,199 shares of the medical equipment provider's stock worth $850,000 after buying an additional 7,190 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in shares of Integer by 4.0% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 21,515 shares of the medical equipment provider's stock worth $2,539,000 after buying an additional 837 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its holdings in shares of Integer by 4.7% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 109,316 shares of the medical equipment provider's stock worth $12,900,000 after buying an additional 4,873 shares in the last quarter. Finally, Millennium Management LLC grew its stake in Integer by 2,408.8% in the first quarter. Millennium Management LLC now owns 123,132 shares of the medical equipment provider's stock valued at $14,531,000 after purchasing an additional 118,224 shares in the last quarter. Institutional investors and hedge funds own 99.29% of the company's stock.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.